Feedback / Questions
RNDO-564 - Rondo Therap
https://www.businesswire.com/news/home/20250408222894/en/Rondo-Therapeutics-Publishes-Preclinical-Data-on-RNDO-564-a-Novel-CD28-x-Nectin-4-Co-Stimulatory-Bispecific-Antibody-for-the-Treatment-of-Bladder-Cancer
Apr 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next